Stress signals elicit a wide variety of cellular responses, many of which converge on the phosphorylation of JNK and p38 kinases, the activation of which has been wellcharacterized. How these kinases are switched o by dephosphorylation is not well understood. Here we describe how diverse cellular stresses aect dierently the stability and activity of a JNK-inactivating dualspeci®city threonine-tyrosine phosphatase M3/6. Both anisomycin and arsenite activate the JNK pathway and, in addition, inactivate the M3/6 phosphatase. However, while anisomycin treatment of cells leads to M3/6 protein degradation, arsenite appears to inactivate M3/6 directly. These results might have implications for the mechanism of tumour promotion by arsenic.
Introduction
Work in the past decade has de®ned two cascades activated preferentially by in¯ammatory cytokines as well as a variety of cellular stresses. The stressactivated cascades comprise of the c-Jun N-terminal kinase (JNK) pathway and the p38 kinase pathway. They mediate among other processes cell cycle delay, cellular repair or apoptosis (reviewed in Ip and Davis, 1998; Chen and Tan, 2000) . As well as being important in the activation of immune responses, they are likely to play a role in cell transformation and cancer (Kyriakis and Avruch, 1996) .
JNKs are members of the mitogen-activated protein kinase (MAPK) family. They are activated by mitogenic stimuli, pro-in¯ammatory cytokines such as TNF-a and IL-1-b and a variety of environmental stresses including UV and ionizing irradiation, osmotic stress, heat shock and oxidative damage (reviewed in Davis, 1999) . These kinases are key regulators of the activity of several transcription factors, including cJun, ATF2 and Elk1 (Kyriakis et al., 1994; Gupta et al., 1995; Whitmarsh et al., 1995) which control cell growth and apoptosis. Activation of the kinases requires phosphorylation at the Thr-Pro-Tyr motif in kinase subdomain VIII and dephosphorylation of either the threonine or tyrosine residue results in the enzymatic inactivation of JNK. This may be achieved either by a serine/threonine phosphatase, or a dualspeci®city phosphatase. This has led to the suggestion that the inhibition of such a phosphatase could be important in the regulation of JNK activity.
The dual-speci®city family of phosphatases have been shown to display broad substrate speci®city towards the MAP kinases (reviewed in Keyse, 2000; Camps et al., 2000) . However some members, in particular M3/6, MKP-5, and MKP-7 demonstrate high selectivity for the SAPK/JNK and p38 kinases (Theodosiou et al., , 1999 Muda et al., 1996; Tanoue et al., 1999 Tanoue et al., , 2001 , while another member, MKP-3, is relatively speci®c for ERK2 Camps et al., 1998) . The factors determining this selectivity have not been completely elucidated, though it has been proposed that several motifs present in the protein sequence of these phosphatases are responsible for substrate binding (Keyse and Ginsburg, 1993; Jacobs et al., 1999; Tanoue et al., 2000) . In addition the recent demonstration that, upon binding to their substrates and following stimulation, these phosphatases can become modi®ed and regulated by MAP kinases Brondello et al., 1999; Johnson et al., 2000; Slack et al., 2001) suggests further complexity in the interaction.
It has been shown that exposure of cells to protein damaging stresses, including arsenite, oxidative stress and heat shock, strongly reduces the rate of JNK dephosphorylation (Cavigelli et al., 1996; Meriin et al., 1999) . In addition, activation of the JNK pathway by As 3+ compounds stimulates the AP-1 transcriptional activity and induces the expression of c-Jun and c-Fos (Cavigelli et al., 1996; Ludwig et al., 1998) . It is, therefore, not surprising that regulation of the JNK pathway by arsenite may be relevant to carcinogenesis induced by this agent. Arsenic is a naturally occurring environmental toxin, chronic exposure to which is associated with increased risk of cancer of the skin, bladder, kidney, lung and colon (reviewed in Snow, 1992; Bernstam and Nriagu, 2000) . Several hypotheses have been proposed to explain how arsenic exposure induces carcinogenesis. These include induction of chromosome aberrations and sister chromatid exchange, DNA hypomethylation triggering aberrant gene expression and induction of c-jun and c-fos gene expression (Ludwig et al., 1998; Zhao et al., 1997) . However, the mechanism by which arsenite might alter JNK activity to aect cell transformation and tumour promotion is unclear.
Here we demonstrate that activation of the JNK pathway by arsenite may be augmented by the inhibition of the activity of a JNK-speci®c phosphatase, M3/6. This is distinct from the eects of another JNK-inducing agent anisomycin, which triggers M3/6 inactivation by ubiquitination, and subsequent proteolytic degradation of the protein.
Results

Conditional expression of the JNK-phosphatase M3/6
To study the mechanism of the inactivation of the JNK pathway by M3/6, we established HEK293 cell lines conditionally expressing catalytically active and inactive forms of the phosphatase. We utilized an ecdysone-inducible expression system in which induction is dependent on addition of ponasterone A, an analogue of the insect steroid hormone ecdysone. EcR293 cell clones stably expressing inducible M3/6 (wild-type), tagged at the Nterminus with a myc epitope tag (EcR293-WT) and catalytically inactive M3/6 similarly tagged (EcR293-C246S) were established. No basal level of expression was detected in the absence of ponasterone A (data not shown). In addition, stable clones expressing bgalactosidase (bGAL) were established and used as control lines (EcR293-bGAL).
To characterize these conditional cell lines, time course assays were carried out to assess the rate and levels of induction of the M3/6 proteins. Western blot analysis demonstrated that there was signi®cant induction in the level of the WT protein 2 h after the addition of ponasterone A, reaching a maximal level after 6 h ( Figure 1a , top panel). The catalytically inactive protein was expressed similarly, though slightly earlier and more abundantly (Figure 1a , bottom panel). To investigate the stability of the induced protein, we performed a time course assay following withdrawal of ponasterone A. Western blot analysis indicated that, after 6 h, both the WT and the mutant M3/6 proteins were no longer present (Figure 1b) . To con®rm this result, we carried out a pulse-chase assay (Figure 1c ). This veri®ed that both wild-type and catalytically inactive proteins are relatively unstable having a halflife of approximately 2 h.
We have shown previously that the M3/6 phosphatase is relatively speci®c for JNK, shows some activity towards p38 but very little activity towards ERK2 MAP kinase (Muda et al., 1996 Smith et al., 1997) . To ascertain whether this is also the case in the EcR293 M3/6 inducible cells, we carried out c-jun kinase assays from cell lysates expressing the M3/6 WT protein, the catalytically inactive (C246S) protein and control cells expressing bGAL. The cells were stimulated with anisomycin (25 ng/ml for 15 min) to activate the JNK pathway. Phosphorylation of GST-cJun in response to anisomycin was detected in the absence of M3/6 WT ( Figure 2a) , whereas in the presence of the phosphatase only a faint band was observed (Figure 2a, upper) . In contrast, substantial phosphorylation of GST-c-Jun was observed when lysates expressing the catalytically inactive M3/6 or the control bGAL, were used for the assay. To con®rm this result, lysates of inducible cell lines stimulated with FCS or anisomycin (as described in Materials and methods) were also immunodetected using a phosphospeci®c JNK antibody (Figure 2a, lower) . Phosphorylation of JNK was observed after anisomycin stimulation in cells expressing the catalytically inactive M3/6, whereas in the presence of the active phosphatase, phosphorylation of JNK was greatly reduced (Figure 2a ). The eect of the M3/6 phosphatase on the phosphorylation of p38 and ERK was assessed by immunodetection using phospho-p38 and phospho-ERK speci®c antibodies respectively. The results (Figure 2b, c) indicate that this phosphatase shows little activity towards p38 and no measurable activity towards ERK1/2.
M3/6 is a phosphoprotein
We investigated whether JNK-activating stress stimuli could have an eect on the M3/6 phosphatase. EcR293-WT cells were starved of serum overnight in the presence of ponasterone A and were subsequently stimulated either with 20% FCS, arsenite or anisomycin (10 mg/ml) for the indicated time periods ( Figure  3a ). These data indicated that the M3/6 WT protein was modi®ed after 30 min treatment with arsenite, as observed by the reduction of the mobility of M3/6 on SDS-polyacrylamide gel electrophoresis. This reduction was even greater after 2 h treatment with arsenite. On the other hand, treatment of cells with serum had no eect on the electrophoretic mobility of M3/6. Interestingly, treatment of the cells with anisomycin (10 mg/ml) for the indicated time points resulted in the steady decrease of the expressed protein, which was no longer visible after 4 h stimulation. It is noteworthy that at this concentration, anisomycin inhibits translation by binding to 60S ribosomal subunits and blocking peptide bond formation (Hazzalin et al., 1998) . To test whether the reduction in M3/6 mobility was a consequence of phosphorylation, we treated extracts of cells stimulated with arsenite with lambda (l) phosphatase. This led to the elimination of the more slowly migrating form of the WT M3/6 ( Figure  3b ), suggesting that the protein is phosphorylated in response to arsenite.
A similar pro®le was observed when the EcR293-C246S cells were treated with arsenite ( Figure 3b ). However, in this case treatment of extracts from unstimulated cells with l phosphatase also increased the mobility of the M3/6 C246S band (Figure 3b) which suggested that the C246S mutant protein might be constitutively phosphorylated. To address this, we carried out in vitro transcription-translation of the M3/6 WT and C246S constructs in rabbit reticulocyte lysates. Using this assay it was clear that the M3/6 C246S protein did indeed migrate more slowly than the wildtype protein (Figure 3c ). Treatment of the in vitro translated M3/6 C246S protein with l phosphatase veri®ed that the mobility dierence was indeed likely to be due to phosphorylation (Figure 3c ). Interestingly, this band shift was only detected when the rabbit reticulocyte system was used; when an in vitro transcription-translation system derived from wheat germ extract was used, both WT and C246S proteins migrated similarly (unpublished observations).
It has recently been shown that the MKP-1 phosphatase which dephosphorylates ERK1 and ERK2 is also a substrate for these kinases (Brondello et al., 1999) . To assess whether the M3/6 protein was phosphorylated by its substrate JNK, in vitro translated proteins were treated with active JNK (Figure 3d ). This led to a shift of the M3/6 WT band. In contrast, the catalytically inactive protein showed no further phosphorylation after treatment with active JNK (Figure 3d ) con®rming the previous ®nding of it being constitutively phosphorylated ( Figure 3c ). To corroborate these in The half-life of the EcR293-WT and CS M3/6 proteins was determined after overnight induction of the proteins with ponasterone A. The following day, the cells were incubated in methionine-free medium for 30 min and labelled with 35 S methionine for a further 1 h in the presence of ponasterone A. Cell aliquots were taken at the indicated times (chase time), the M3/6 protein was immunoprecipitated and resolved on SDS ± PAGE, blotted on a PVDF membrane and subjected to autoradiography. Subsequently, the membrane was rehydrated and immunoblotted with 9E10 antibody vitro ®ndings, EcR293 cells expressing M3/6 WT were treated either with SB203580 (a p38 kinase inhibitor) or with U0126 (a MEK1 inhibitor) prior to stimulation (Cuenda et al., 1995; Favata et al., 1998) . These data ( Figure 3e ) indicate that neither p38 nor ERK kinase activities are required for the shift in mobility associated with M3/6 phosphorylation in response to arsenite.
Effect of stress stimuli on the activity of the M3/6 protein
Having shown that the M3/6 protein becomes phosphorylated after treatment with arsenite, we wanted to examine whether another stress stimulus, anisomycin, had a similar eect. Previously ( Figure 3a ) we had used anisomycin at 10 mg/ml, at which concentration it acts as a protein translation inhibitor. EcR293-WT and EcR293-C246S cells were treated with arsenite and anisomycin (25 ng/ml for 15 min). The eects on the mobility of the M3/6 protein, in the soluble fraction, were assessed by immunoblotting using the 9E10 antibody (Figure 4a, upper) . Arsenite treatment results in the complete shift of the M3/6 band, whereas after 15 min anisomycin treatment there is still signi®cant amount of the unphosphorylated form of M3/6. A similar pro®le is observed for the C246S protein. However, in this instance the shift after anisomycin treatment is complete. Moreover, the protein is expressed at much higher levels than its wild-type counterpart (Figure 4a ). Attempts to carry out phosphatase assays using immunoprecipitated M3/6 proteins from EcR293 cells treated with arsenite or anisomycin have been unsuccessful. It was therefore not possible to conclude whether the phosphorylation of the M3/6 protein had any substantial eects on its activity. It is noteworthy that, after both arsenite and anisomycin treatment there is a substantial decrease in the amount of M3/6 WT protein present. To assess whether this is the result of precipitation, aliquots of the pellets insoluble after sample preparation were resolved by electrophoresis. Interestingly, after arsenite treatment equal amounts of protein was present in the soluble and insoluble fractions. By contrast, the M3/6 WT protein remained completely soluble after challenging the cells with anisomycin.
Anisomycin treatment has a striking eect on the activation of the JNK pathway, which is not detected in the absence of stress (Figure 4a ). However, induction of M3/6 WT protein is sucient to cause almost complete dephosphorylation of JNK. Interestingly though, treatment of cells with arsenite appears to diminish substantially the ability of the M3/6 phosphatase to dephosphorylate JNK (Figure 4a) . Moreover it appears that, even though these stress stimuli aect the solubility of the M3/6 WT protein, the solubility of the phosphorylated JNK forms remains unaltered.
It has been suggested that arsenite exerts its eects both by activation of the SEK1/JNK pathway, but also by inhibiting a JNK speci®c phosphatase (Meriin et al., 1999) . To test this, EcR293-WT cells were transiently transfected with an HA-tagged SEK1 construct. After stimulation with arsenite and anisomycin, the immunoprecipitated HA-SEK1 protein was assayed for its kinase activity using as substrate a mutant (K55R) of GSTSAPKb, which lacks the ability to autophosphorylate (Figure 4b ). These results demonstrate that both arsenite and anisomycin activate SEK1, resulting in the phosphorylation of GST-SAPKb K55R. However, it appears that the presence or absence of the M3/6 WT protein has no eect on the pathway upstream of JNK.
Effect of anisomycin on the activity of the M3/6 protein
We found that stimulation of the JNK pathway with anisomycin has a distinct eect on the M3/6 protein Figure 2 Eect of induction of M3/6 WT and C246S in EcR293 cells on the activity of JNK, p38 and ERK. EcR293-WT and -C246S cells were incubated overnight in serum-free medium in the presence of ponasterone A and then stimulated either with anisomycin (25 ng/ml for 15 min), or with FCS (20% for 15 min) or left unstimulated. Cells were lysed on ice and lysates were subjected to SDS ± PAGE. (a) Top panel: the activity of JNK was assayed by c-Jun phosphorylation as outlined in Materials and methods. Lower panel: JNK activity was also determined using a phospho-JNK speci®c antibody. (b) The activity of the p38 kinase was measured by immunoblotting with antibody speci®c for phosphorylated (active) p38. (c) The same blot (a, lower panel) was stripped and reprobed with antibody speci®c for phosphorylated ERK1/2 depending on the concentration of anisomycin used. When cells were treated with 10 mg/ml anisomycin for 4 h, the M3/6 WT protein was no longer visible. After stimulation with 25 ng/ml anisomycin for 15 min (Figure 4a) , the M3/6 protein appeared shifted, suggesting it had become phosphorylated. To gain a better insight into the eect of anisomycin on the activity of M3/6 and the stimulation of the JNK pathway, we carried out a time-course assay using both EcR293-WT and -C246S cell lines which were stimulated with subinhibitory concentration of anisomycin (25 ng/ml) for the indicated periods ( Figure 5) . Anisomycin stimulation at this concentration appears to have a distinct eect on the expression of the M3/6 WT protein. After 10 min stimulation, the protein level begins to decrease and continues to do so even after 1 h ]methionine/cysteine, using the rabbit reticulocyte lysate system. The in vitro translation products were treated with lambda phosphatase, resolved by SDS ± PAGE (12.5% gel) and autoradiographed. (d) In vitro translation products were incubated with active GST-SAP kinase a (1 mg) in an in vitro kinase assay (see Materials and methods). Samples were separated by SDS ± PAGE and autoradiographed. (e) Eect of inhibitors of p38 (PD203580) and MEK1 (U0126) on stress-induced phosphorylation of M3/6. EcR293-WT cells were pretreated with vehicle (DMSO) control or 2 mM SB203580 or 10 mM U0126 for 30 min prior to stimulation with 20% FCS for 30 min, 500 mM sodium arsenite for 1 h or left unstimulated. The M3/6 protein was immunodetected using the anti-myc antibody 9E10 stimulation, by which point, the M3/6 WT protein is hardly visible. Interestingly, after 15 min of anisomycin treatment, a phosphorylated form of the protein appears which is still present after 1 h (Figure 5a ). Four hours after stimulation, there is an increase in the intensity of the lower unphosphorylated form of the protein, whereas the upper band has disappeared. This pro®le correlates with the time-course of anisomycinstimulated activation of JNK, which peaks at 15 ± 60 min and then decreases to residual levels by 2 ± 3 h (Hazzalin et al., 1998) . It is therefore unsurprising that at 4 h, anisomycin appears to have no eect on the protein (Figure 5a ). In comparison, the catalytically inactive protein appears to become phosphorylated at an earlier timepoint (5 min) and remains so even after 4 h. We have con®rmed that this shift is likely due to phosphorylation by treatment of these cell extracts with l phosphatase which results in the disappearance of the upper band (data not shown). The Western blot generated in this experiment was reprobed with an antibody that recognizes only the phosphorylated forms of JNK1 and JNK2 (Figure 5b ). This demonstrates clearly that, after 15 min stimulation with anisomycin, the presence of the M3/6 WT phosphatase leads to a considerable decrease of the phosphorylated JNK. This result suggests that the expressed phosphatase is dephosphorylating JNK to a certain extent ( Figure  5b ). On the other hand, stimulation of EcR293-C246S cells with anisomycin causes a rapid and sustained JNK activation even after 4 h.
Lactacystin prevents M3/6 degradation following anisomycin treatment
Many labile proteins are targeted for degradation by the ubiquitin-directed proteasome complex (King et al., 1996) . Therefore, we determined whether the proteasome inhibitor lactacystin (Fenteany et al., 1995) had any eect on the stability and expression levels of M3/6 after anisomycin stimulation. Cells were starved of serum, treated with lactacystin (10 mM) overnight and then stimulated with anisomycin (25 ng/ml) for the indicated periods ( Figure 6 ). These data indicate that the presence of the proteasome inhibitor lactacystin reduces the rate of degradation of the M3/6 WT protein (Figure 6a ). Furthermore, it is clear that there is rapid phosphorylation of the protein in response to anisomycin which may have not been obvious previously (compare with Figure 5a ). After 15 min stimulation there are almost equal amounts of the two forms (phosphorylated and non-phosphorylated) present, whereas after 1 h anisomycin treatment the protein is predominantly in the phosphorylated form, which persists even after 4 h. By this time however, the unphosphorylated form of the protein is also expressed. Lactacystin also appears to increase the stability of the phosphorylated form of the protein (Figure 6a ). Catalytically inactive M3/6 is also somewhat stabilized after treatment with lactacystin ( Figure  6a) ; this is consistent with our previous ®ndings ( Figure  5a ) suggesting that this form of the protein is much more intrinsically stable.
Interestingly, the stabilization of the M3/6 WT protein due to the treatment with lactacystin resulted in the complete dephosphorylation of JNK (Figure 6b ). This eect on the activity of JNK does not appear to be due to the presence of lactacystin ( Figure 6b ). As expected, the catalytically inactive protein does not dephosphorylate JNK. Moreover, it appears that expression of this mutant protein enhances the stimulation of the JNK pathway by anisomycin ( Figure  6b ). It is possible that this protein has a dominant negative eect on the JNK pathway, increasing the activity of the downstream kinase. Such eects have previously been demonstrated for the Cys ? Ser MKP-1 mutant (Sun et al., 1993) .
Discussion
There is increasing evidence implicating the JNK pathway in apoptotic cell death, as well as cell survival Eect of the M3/6 phosphatase on SEK1 in response to stress. EcR293 cells either expressing M3/6 WT (+ponasterone A) or not (7ponasterone A) were transfected with an HA-tagged SEK1 construct. The cells were allowed to grow for 24 h posttransfection, and were then serum-starved overnight. The following day cells were stimulated as in (a) and SEK1 protein was immunoprecipitated using an anti-HA antibody. The SEK1 activity was measured using GST-SAPKb K55R as a substrate (see Materials and methods). The samples were resolved by SDS ± PAGE and subjected to autoradiography and proliferation (reviewed in Chen and Tan, 2000; Davis, 2000) . In the past few years, the mechanisms by which apoptotic stimuli induce JNK activation thus leading to cell death have been uncovered (Tournier et al., 2000) . Furthermore, it has been shown that the JNK pathway is constitutively activated in various tumour cell lines and is essential for the transforming activity of various oncogenes, including met and bcrabl (Rodrigues et al., 1997; Garcia-Guzman et al., 1999; Raitano et al., 1995) . However, the precise mechanism of JNK action during transformation is not understood.
Cells have the ability to interpret JNK activation in dierent ways depending upon context. An emerging hypothesis is that sustained activation of JNK leads to apoptosis, while a transient activation of this pathway may trigger a survival signal. It seems likely that a JNK phosphatase could play an important role in Figure 5 Eect of anisomycin on the M3/6 protein and its activity. EcR293-WT and -C246S cells were incubated overnight in serum-free medium with or without ponasterone A. The following day, they were treated with anisomycin (25 ng/ml) for the indicated timepoints. Cells were lysed on ice and the extracts analysed by SDS ± PAGE. (a) Immunodetection of the M3/6 protein using the anti-myc antibody (9E10). (b) The same blot was stripped and re-probed with anti-phospho-JNK antibody. (c) The blot was re-probed with an anti-tubulin antibody as a loading control Figure 6 Eect of the proteasome inhibitor lactacystin on the M3/6 protein and its activity. EcR293-WT and -C246S cells in the presence or absence of ponasterone A were treated with 10 mM lactacystin overnight in serum-free medium. Cells were then treated with anisomycin (25 ng/ml) for the indicated timepoints. Total cell extracts were analysed by SDS ± PAGE. (a) Immunodetection of the M3/6 protein using anti-myc antibody (9E10). (b) The same blot was stripped and re-probed with anti-phospho-JNK antibody. (c) The same blot was re-probed with anti-tubulin loading control controlling the duration of JNK activation. Furthermore, Meriin et al. (1999) recently reported that certain JNK inducing protein damaging stresses act through inhibition of JNK dephosphorylation. To assess whether such stresses had any eect on M3/6, a JNK-speci®c phosphatase, we established cell lines inducibly expressing the catalytically active and inactive forms of the phosphatase.
We show here that both the M3/6 WT and C246S proteins are rapidly phosphorylated in response to arsenite and anisomycin treatment. Intriguingly, phosphorylation can be mediated by JNK, the substrate of M3/6. The catalytically inactive mutant of M3/6 displays partial constitutive phosphorylation (Figures  3b and 4a) . This suggests that, under resting conditions, there is sucient residual JNK activity to cause the phosphorylation of the M3/6 C246S protein. This mutant may act as a`substrate trap', binding to JNK stably rather than the more transient interaction of its wild-type counterpart (Sun et al., 1993) . Such stable interaction with JNK could explain why attempts to derive cell lines constitutively expressing M3/6 C246S have been unsuccessful (authors unpublished observations; Johnson et al., 2000) .
Other members of the dual-speci®city family of phosphatases (MKP-3 and MKP-1) have also been shown to be phosphorylated by their substrates Brondello et al., 1999) . In particular, phosphorylation of MKP-1 by ERK1/2 appears to lead to stabilization of the protein which has a half-life of about 45 min (Brondello et al., 1999) . We and others (Johnson et al., 2000) have shown that the half-life of the M3/6 WT protein is approximately 2 h. The relatively short half-life of M3/6 could be in part explained by the presence of three PEST regions within its carboxy-terminus ; such regions are thought to target proteins for rapid degradation (Rechsteiner and Rogers, 1996) . It is not clear whether phosphorylation of M3/6 by JNK alters the half-life of this phosphatase, aects the binding of the two proteins or whether it occurs as indirect consequence of this interaction.
It was recently reported that treatment of cells with osmotic stress, UV irradiation and anisomycin activated JNK without aecting its dephosphorylation, whereas exposure to stresses such as arsenite, heat shock and ethanol caused JNK activation through inhibition of its dephosphorylation. Here, we studied the eect of two of these stimuli on the activity of the M3/6 phosphatase, which is JNK speci®c. Treatment of the EcR293-WT cells with anisomycin, at concentrations below those that inhibit protein translation (25 ng/ml) (Hazzalin et al., 1998) , resulted in the destabilization of the M3/6 WT protein and its degradation (Figure 5a ). However, pretreatment of the cells with the proteasome inhibitor lactacystin, prevented the degradation of this phosphatase ( Figure  6a ). We have veri®ed this ®nding by transient transfection of the EcR293-WT cells with a tagged ubiquitin construct. Lactacystin treatment, followed by anisomycin stimulation, led to the accumulation of multiubiquitinated forms of M3/6 (data not shown). It is evident that after anisomycin stimulation, the M3/6 WT protein is phosphorylated. However, it would appear that this phosphorylation does not aect the activity of the phosphatase; upon lactacystin treatment, after 1 h stimulation with anisomycin, the majority of the protein is phosphorylated, yet fully active ( Figure  6b ). It is noteworthy that catalytically inactive M3/6 is consistently more stable in response to anisomycin. As this form of the protein appears to be stably bound to JNK, this raises the question of whether this stability is conferred by this association.
A plausible scenario to explain this data is that, in the absence of any stimulation, M3/6 has a half-life of about 2 h, which is greatly reduced after anisomycin challenge. Such stimulation results in the activation of JNK via SEK1, and its subsequent binding by M3/6 (Figure 7 ). This binding has three dierent outcomes: the dephosphorylation of JNK by M3/6, the phosphorylation of M3/6 by active JNK and the targeting of M3/6 for degradation via ubiquitination. However, in the case of the catalytically inactive mutant this binding results in the formation of a stable complex between M3/6 and active JNK and leads to full phosphorylation of the M3/6 C246S protein. Under resting conditions the catalytically inactive protein is only partially phosphorylated and therefore only partially protected from degradation (Figures 3b and  4a ) explaining why the WT and C246S proteins have similar half-lives.
A similar model has been proposed for the interaction between the transcription factor c-Jun and JNK (reviewed in Fuchs et al., 1998) . This interaction is mediated by the delta (d) domain present in c-Jun (Baichwal and Tjian, 1990; Adler et al., 1994) . It has also been shown that this domain is required for the ubiquitination and subsequent degradation of c-Jun by JNK under resting conditions (Treier et al., 1994; Fuchs et al., 1997) . Moreover, phosphorylation of cJun by activated JNK, protects the latter from ubiquitination and prolongs its half-life (Fuchs et al., 1996) . Inspection of the M3/6 amino acid sequence reveals the presence of a potential delta-domain (residues 391 to 400), which conforms well with the consensus based on the sequences of the Jun proteins is K/R-X-X/K/R-K/R-X (1 ± 4) -L/I-X-L/I (Jacobs et al., 1999) . Further work is currently underway to address whether this domain in M3/6 mediates its interaction with JNK and is required for its ubiquitination.
Arsenite stimulation has a dierent eect to anisomycin on the M3/6 phosphatase. We have consistently observed that it produces a supershift of the mobility of the protein (Figure 4a ). It has been suggested previously that As 3+ may bind to thiol groups in the catalytic site of a JNK-speci®c phosphatase (Cavigelli et al., 1996) . It is, therefore, plausible that the detected shift is partly due to a conformational change of the M3/6 protein, in addition to phosphorylation, as treatment of arsenite stimulated cell lysates with l phosphatase results in the incomplete collapse of the mobility shift (Figure 3b ).
However, an alternative possibility is that some of the phosphorylated sites on M3/6 may not be accessible to the lambda phosphatase. We show here that arsenite activates the JNK pathway via SEK1 activation, which is in agreement with previously published data (Meriin et al., 1999) . M3/6 is the ®rst example of a JNKspeci®c phosphatase inhibited by arsenite (Cavigelli et al., 1996; Meriin et al., 1999) . The mechanism by which arsenite exerts its inhibitory eect on M3/6 is not yet clear. However, it appears that arsenite stimulation results partly in the precipitation, and therefore inactivation, of the M3/6 protein. Heat shock treatment also results in the precipitation of the M3/6 protein; however, in this instance, the eect is much more pronounced (data not shown). This is unsurprising, since the response of cells to arsenic compounds is in many respects similar to their response to heat stress (reviewed in Bernstam and Nriagu, 2000) .
Using our experimental system we propose a model (Figure 7 ) whereby some cellular stresses such as arsenite (and heat shock) inhibit JNK dephosphorylation by direct inactivation of M3/6 and its precipitation. On the other hand anisomycin, activates the JNK pathway via activation of its upstream kinase SEK1, but ultimately also resulting in the degradation of this phosphatase via ubiquitination. The high sensitivity of humans to arsenic compounds, the absence of appropriate animal models and the lack of detailed knowledge as to how arsenic exerts its toxic and carcinogenic eects, make it important to elucidate the exact mechanism involved in the inactivation of M3/6 by arsenite.
Materials and methods
Generation of stable cell lines with inducible M3/6 expression
To generate stable transfectants with inducible M3/6 expression, human transformed primary embryonal kidney cells (HEK293) transfected with pVgRXR (293VgRXR, Invitrogen) were utilized. This construct (pVgRXR) encodes the heterodimeric ecdysone/retinoid X receptor, which binds to the ecdysone response element (present in pIND) in the presence of ponasterone A . 293VgRXR cells were transfected with pIND-M3/6, pIND-M3/6 C246S and pIND-bGAL, using LipofectAMINE (Gibco, BRL) according to manufacturer's instructions. Stable transfectants were selected in DMEM supplemented with 10% FCS, 2 mM Lglutamine, penicillin (100 U/ml) streptomycin (100 mg/ml), Geneticin (1 mg/ml) (Life Technologies, Inc.) and Zeocin (200 mg/ml).
Measurement of JNK activity
JNK activity was assayed using a pull-down assay. Cells were stimulated appropriately, washed twice with ice-cold phosphate-buered saline (PBS) and lysed in the following lysis buer (20 mM HEPES (pH 8.0), 75 mM NaCl, 0.1% Triton X-100, 2.5 mM MgCl 2 , 0.1 mM EDTA, 20 mM b-glycerophosphate, 1 mM Na 3 VO 4 and 16 protease inhibitor cocktail (Boehringer Mannheim)). Cell lysates (250 mg) were incubated with 5 mg recombinant glutathione S-transferase (GST)-Jun (amino acids 1 ± 131) fusion protein, for 3 h at 48C. Kinase assays were performed as previously described (Smith et al., 1997) . The activation of JNK was also determined by using an antibody speci®c to the phosphorylated forms of JNK (Promega).
Measurement of SEK1 activity
EcR293-WT cells (+ponasterone A), plated out in 50 mm diameter dishes to 70% con¯uency, were transiently transfected with 2.5 mg HA-SEK1 plasmid DNA, using LipofectAMINE reagent as previously described (Theodosiou et al., 1999) . After 24 h the cells were incubated in serum-free DMEM+ponasterone A as indicated. The following day, cells were stimulated with various agents, lysed as described above and the exogenously expressed SEK1 protein was immunoprecipitated using the HA epitope speci®c antibody (Santa Cruz), precoupled to protein A-Sepharose beads (Sigma). The beads were washed three times with ice-cold HBIB buer (20 mM HEPES (pH 8.0), 0.05% Triton X-100, 50 mM NaCl, 2.5 mM MgCl 2 , 0.1 mM EDTA, 20 mM bglycerophosphate and 100 mM Na 3 VO 4 ) and twice with kinase buer (20 mM HEPES (pH 8.0), 20 mM b-glycerophosphate, 20 mM MgCl 2 , 100 mM Na 3 VO 4 and 0.5 mM DTT). The reactions were carried out in 30 ml kinase buer containing 10 mM cold ATP, 2 mCi of [g-32 P]ATP and 5 mg GST-SAPKb K55R, for 30 min at 308C. Kinase assays were terminated in gel sample buer, heated to 1008C for 5 min and separated by SDS ± PAGE. The gel was dried and autoradiographed.
Measurement of ERK1 and -2, and p38 kinase activities Activities of the ERK1 and -2 and p38 kinases were measured by immunoblotting with antibodies speci®c to phosphorylated (active) kinases in cell lysates (purchased from Sigma and New England Biolabs respectively).
In vitro translation assays
The M3/6 WT and C246S cDNAs were translated in vitro using the TNT Coupled Reticulocyte Lysate System (Promega) according to the manufacturer's instructions. [ 35 S]methionine was purchased from Amersham. An aliquot of the translated product (2 ml) was diluted in 30 ml assay dilution buer (20 mM MOPS (pH 7.2), 25 mM b-glyceropho- Figure 7 Model of the regulation of the M3/6 (wild-type) phosphatase by arsenite and anisomycin sphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM dithiothreitol), containing 20 mM ATP and 2.5 mM MgCl 2 . Reactions were carried out after adding 2 mg active SAPK1a (TCS Biological Ltd) per sample, at 308C for 30 min and were terminated by adding 56 SDS sample buer. Lambda protein phosphatase was used according to the manufacturer's instructions (New England Biolabs).
Extract preparation and Western blot analysis
Cells were washed twice with ice-cold PBS and lysed on ice in RIPA buer (50 mM Tris (pH 8.0), 150 mM NaCl, 0.1% SDS, 0.1% deoxycholate, 1% Triton X-100, 50 mM NaF, 1 mM Na 3 VO 4 and 16 protease inhibitor cocktail (Boehringer Mannheim)]. Extracts were separated by centrifugation at 14 000 g for 10 min at 48C, into soluble (supernatant) and insoluble (pellet) fractions. Typically, 60 mg of soluble protein was separated by SDS-polyacrylamide gel electrophoresis on a 12.5% gel, followed by transfer to nitrocellulose membranes. The pellets were resuspended in 26 Laemmli buer and proteins were solubilized by homogenization (through a 21G needle) and boiling.
Pulse-chase experiments
EcR293-WT (+ponasterone A) cells were subjected to pulsechase analysis at 60 ± 70% con¯uency on 50 mm diameter dishes. Cells were starved of methionine and cysteine for 30 min prior to labelling. They were labelled with 200 mCi [ 35 S]methionine/cysteine (Trans 35 S-label; ICN) per plate in methionine/cysteine-free DMEM at 378C for 1 h. After labelling, cells were washed and incubated with chase medium (methionine/cysteine-free DMEM supplemented with 10-fold L-methionine and L-cysteine; Gibco BRL) for the indicated amount of time in the presence of ponasterone A. Cell extracts were subsequently subjected to immunoprecipitation using the myc epitope speci®c antibody.
Abbreviations HEK293 cells, human embryonic kidney 293 cells; JNK, cJun N-terminal kinase; SAPK, stress-activated protein kinase; ERK, extracellular signal-regulated kinase; SEK1, SAPK/ERK kinase 1; DMSO, dimethyl sulphoxide; FCS, foetal calf serum; GST, glutathione S-transferase
